BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37664045)

  • 21. The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia.
    Lühmann JL; Stelter M; Wolter M; Kater J; Lentes J; Bergmann AK; Schieck M; Göhring G; Möricke A; Cario G; Žaliová M; Schrappe M; Schlegelberger B; Stanulla M; Steinemann D
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Groundbreaking Validation of Whole Genome Sequencing (WGS) for a Comprehensive Genetic Profiling of Childhood B-cell ALL.
    Garcia-Heras J
    J Assoc Genet Technol; 2023; 49(4):156-161. PubMed ID: 38049150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ONT long-read WGS for variant discovery and orthogonal confirmation of short read WGS derived genetic variants in clinical genetic testing.
    Kaplun L; Krautz-Peterson G; Neerman N; Stanley C; Hussey S; Folwick M; McGarry A; Weiss S; Kaplun A
    Front Genet; 2023; 14():1145285. PubMed ID: 37152986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
    Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.
    Kimura S; Montefiori L; Iacobucci I; Zhao Y; Gao Q; Paietta EM; Haferlach C; Laird AD; Mead PE; Gu Z; Stock W; Litzow M; Rowe JM; Luger SM; Hunger SP; Ryland GL; Schmidt B; Ekert PG; Oshlack A; Grimmond SM; Rehn J; Breen J; Yeung D; White DL; Aldoss I; Jabbour EJ; Pui CH; Meggendorfer M; Walter W; Kern W; Haferlach T; Brady S; Zhang J; Roberts KG; Blombery P; Mullighan CG
    Blood; 2022 Jun; 139(24):3519-3531. PubMed ID: 35192684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of whole genome sequencing from blood versus saliva derived DNA in cardiac patients.
    Yao RA; Akinrinade O; Chaix M; Mital S
    BMC Med Genomics; 2020 Jan; 13(1):11. PubMed ID: 31996208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia.
    Vosberg S; Herold T; Hartmann L; Neumann M; Opatz S; Metzeler KH; Schneider S; Graf A; Krebs S; Blum H; Baldus CD; Hiddemann W; Spiekermann K; Bohlander SK; Mansmann U; Greif PA
    Genes Chromosomes Cancer; 2016 Jul; 55(7):553-67. PubMed ID: 27015608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content.
    Ganesamoorthy D; Robertson AJ; Chen W; Hall MB; Cao MD; Ferguson K; Lakhani SR; Nones K; Simpson PT; Coin LJM
    BMC Cancer; 2022 Jan; 22(1):85. PubMed ID: 35057759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.
    Liu YF; Wang BY; Zhang WN; Huang JY; Li BS; Zhang M; Jiang L; Li JF; Wang MJ; Dai YJ; Zhang ZG; Wang Q; Kong J; Chen B; Zhu YM; Weng XQ; Shen ZX; Li JM; Wang J; Yan XJ; Li Y; Liang YM; Liu L; Chen XQ; Zhang WG; Yan JS; Hu JD; Shen SH; Chen J; Gu LJ; Pei D; Li Y; Wu G; Zhou X; Ren RB; Cheng C; Yang JJ; Wang KK; Wang SY; Zhang J; Mi JQ; Pui CH; Tang JY; Chen Z; Chen SJ
    EBioMedicine; 2016 Jun; 8():173-183. PubMed ID: 27428428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical interpretation and implications of whole-genome sequencing.
    Dewey FE; Grove ME; Pan C; Goldstein BA; Bernstein JA; Chaib H; Merker JD; Goldfeder RL; Enns GM; David SP; Pakdaman N; Ormond KE; Caleshu C; Kingham K; Klein TE; Whirl-Carrillo M; Sakamoto K; Wheeler MT; Butte AJ; Ford JM; Boxer L; Ioannidis JP; Yeung AC; Altman RB; Assimes TL; Snyder M; Ashley EA; Quertermous T
    JAMA; 2014 Mar; 311(10):1035-45. PubMed ID: 24618965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole Genome Sequencing Increases Molecular Diagnostic Yield Compared with Current Diagnostic Testing for Inherited Retinal Disease.
    Ellingford JM; Barton S; Bhaskar S; Williams SG; Sergouniotis PI; O'Sullivan J; Lamb JA; Perveen R; Hall G; Newman WG; Bishop PN; Roberts SA; Leach R; Tearle R; Bayliss S; Ramsden SC; Nemeth AH; Black GC
    Ophthalmology; 2016 May; 123(5):1143-50. PubMed ID: 26872967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.
    Ching T; Duncan ME; Newman-Eerkes T; McWhorter MME; Tracy JM; Steen MS; Brown RP; Venkatasubbarao S; Akers NK; Vignali M; Moorhead ME; Watson D; Emerson RO; Mann TP; Cimler BM; Swatkowski PL; Kirsch IR; Sang C; Robins HS; Howie B; Sherwood A
    BMC Cancer; 2020 Jun; 20(1):612. PubMed ID: 32605647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole-genome characterization in pedigreed non-human primates using genotyping-by-sequencing (GBS) and imputation.
    Bimber BN; Raboin MJ; Letaw J; Nevonen KA; Spindel JE; McCouch SR; Cervera-Juanes R; Spindel E; Carbone L; Ferguson B; Vinson A
    BMC Genomics; 2016 Aug; 17(1):676. PubMed ID: 27558348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-genome sequencing analysis of CNV using low-coverage and paired-end strategies is efficient and outperforms array-based CNV analysis.
    Zhou B; Ho SS; Zhang X; Pattni R; Haraksingh RR; Urban AE
    J Med Genet; 2018 Nov; 55(11):735-743. PubMed ID: 30061371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia.
    Bedics G; Egyed B; Kotmayer L; Benard-Slagter A; de Groot K; Bekő A; Hegyi LL; Bátai B; Krizsán S; Kriván G; Erdélyi DJ; Müller J; Haltrich I; Kajtár B; Pajor L; Vojcek Á; Ottóffy G; Ujfalusi A; Szegedi I; Tiszlavicz LG; Bartyik K; Csanádi K; Péter G; Simon R; Hauser P; Kelemen Á; Sebestyén E; Jakab Z; Matolcsy A; Kiss C; Kovács G; Savola S; Bödör C; Alpár D
    Br J Cancer; 2023 Aug; 129(3):455-465. PubMed ID: 37340093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mutational landscape in pediatric acute lymphoblastic leukemia deciphered by whole genome sequencing.
    Lindqvist CM; Nordlund J; Ekman D; Johansson A; Moghadam BT; Raine A; Övernäs E; Dahlberg J; Wahlberg P; Henriksson N; Abrahamsson J; Frost BM; Grandér D; Heyman M; Larsson R; Palle J; Söderhäll S; Forestier E; Lönnerholm G; Syvänen AC; Berglund EC
    Hum Mutat; 2015 Jan; 36(1):118-28. PubMed ID: 25355294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol.
    Jung M; Schieck M; Hofmann W; Tauscher M; Lentes J; Bergmann A; Stelter M; Möricke A; Alten J; Schlegelberger B; Schrappe M; Zimmermann M; Stanulla M; Cario G; Steinemann D
    Genes Chromosomes Cancer; 2020 Nov; 59(11):667-671. PubMed ID: 32592278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.
    Simons MJHG; Retèl VP; Ramaekers BLT; Butter R; Mankor JM; Paats MS; Aerts JGJV; Mfumbilwa ZA; Roepman P; Coupé VMH; Uyl-de Groot CA; van Harten WH; Joore MA
    Pharmacoeconomics; 2021 Dec; 39(12):1429-1442. PubMed ID: 34405371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study.
    Haider Z; Wästerlid T; Spångberg LD; Rabbani L; Jylhä C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hägglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
    Front Oncol; 2023; 13():1176698. PubMed ID: 37333831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clinically validated whole genome pipeline for structural variant detection and analysis.
    Neerman N; Faust G; Meeks N; Modai S; Kalfon L; Falik-Zaccai T; Kaplun A
    BMC Genomics; 2019 Jul; 20(Suppl 8):545. PubMed ID: 31307387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.